Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesothelioma
- 1 January 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 58 (1) , 80-91
- https://doi.org/10.1016/0090-1229(91)90150-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytesCellular Immunology, 1989
- Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cellsCellular Immunology, 1989
- Lysis of Human Malignant Mesothelioma Cells by Natural Killer (NK) and Lymphokine-activated Killer (LAK) CellsAmerican Review of Respiratory Disease, 1989
- Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharideJournal of Biological Chemistry, 1989
- Mechanisms of lymphocyte-mediated lysisJournal of Cellular Biochemistry, 1989
- Concomitant production of different lymphokines in activated T cellsEuropean Journal of Immunology, 1988
- Perforin‐Dependent and ‐Independent Pathways of Cytotoxicity Mediated by LymphocytesImmunological Reviews, 1988
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cellsExperimental Cell Research, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987